Using genetically engineered mice for radiation research

David G Kirsch1

  • 1Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA. david.kirsch@duke.edu

Radiation Research
|August 27, 2011
PubMed

Insights

Genetic engineering in mice, using the Cre-loxP system, reveals p53

Area of Science:

  • Radiation biology
  • Genetics
  • Cancer research

Background:

  • The laboratory mouse is a long-standing model for radiation research.
  • Genetic engineering advances enable precise gene deletion in mice.
  • Spatial and temporal gene manipulation offers new research avenues.

Purpose of the Study:

  • To investigate the role of genes in normal tissue and tumor responses to radiation.
  • To study mechanisms of acute and late radiation injury using genetically modified mice.
  • To explore tumor response to radiation therapy using engineered mouse models.

Main Methods:

  • Utilizing the Cre-loxP system for cell-type specific gene deletion in mice.
  • Targeting genes like p53 to study radiation response.
  • Generating primary tumors in mice for radiation therapy studies.

Main Results:

  • p53 deletion in the gastrointestinal (GI) epithelium prevents radiation-induced GI syndrome.
  • p53 is essential in endothelial and/or hematopoietic cells to prevent late radiation effects.
  • Genetically engineered mice models are effective for studying tumor response to radiation.

Conclusions:

  • Genetic engineering in mice provides a powerful system to study radiation effects.
  • p53 plays critical roles in mitigating acute and late radiation injury.
  • These models advance understanding of normal tissue response and cancer radiotherapy.